National Coverage Analysis (NCA) for Aprepitant for Chemotherapy-Induced Emesis (CAG-00248R)
Select the ’Print Record’, ‘Add to Basket’ or ‘Email Record’ buttons to print the record, to add it to your basket or to email the record.
Cheryl Gilbreath, PharmD, MBA, R.Ph
410-786-5919
First reconsideration for Aprepitant for Chemotherapy-Induced Emesis (this document)
